Literature DB >> 15163024

Use of p63/P504S monoclonal antibody cocktail in immunohistochemical staining of prostate tissue.

David E Tacha1, Rodney T Miller.   

Abstract

Diagnosis of prostate needle biopsies can be challenging, particularly when the atypical areas of interest are very small. The utility of immunostains for high-molecular-weight cytokeratin (34betaE12) to highlight prostatic basal cells in these cases is well established, and recent reports also document the utility of immunostains for p63 (a marker that stains the nuclei of prostate basal cells) for this purpose. Several investigators have demonstrated that immunostaining for P504S, a cytoplasmic protein that is overexpressed in a high percentage of prostate cancers and in many cases of high-grade prostatic intraepithelial neoplasia (PIN), can also be of use in the diagnosis of prostate biopsies. Because of the cytoplasmic localization of P504S and nuclear localization of p63, the authors hypothesized that a cocktail of these two antibodies might allow simultaneous demonstration of P504S and p63 using a single immunostain. In this report the authors describe the successful use of a cocktail of p63/P504S for immunohistochemical staining of prostate tissue. Two different staining approaches were investigated, with essentially identical results. This cocktail localizes P504S in the cytoplasm of prostate carcinoma cells and high-grade PIN and demonstrates the nuclei of prostatic basal cells, providing information on both the status of P504S and the presence or absence of basal cells with a single immunostain. This cocktail can be of great utility in the examination of diagnostically challenging prostate specimens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163024     DOI: 10.1097/00129039-200403000-00014

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  7 in total

Review 1.  Altered metabolism and mitochondrial genome in prostate cancer.

Authors:  G D Dakubo; R L Parr; L C Costello; R B Franklin; R E Thayer
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

2.  Evaluation of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens.

Authors:  Kitty Pavlakis; Konstantinos Stravodimos; Theodoros Kapetanakis; Alkiviadis Gregorakis; Sofia Athanassiadou; Olympia Tzaida; Constantinos Constantinides
Journal:  Int Urol Nephrol       Date:  2009-08-05       Impact factor: 2.370

3.  Case report: gastric adenocarcinoma metastatic to the prostate gland.

Authors:  Ping Zhang; Yuanyi Zheng; Haitao Ran; Zhi Leng; Zhigang Wang
Journal:  J Radiol Case Rep       Date:  2010-03-01

4.  A new Ki-67 / E-cadherin cocktail reduces inter-observer variation of the calculated proliferative index.

Authors:  Golan Bubis; Ohad Hilly; Roy Bubis; Marisa Halpern; Ariel Schwartz; Rumelia Koren; Lea Rath-Wolfson
Journal:  Pathol Oncol Res       Date:  2013-07-07       Impact factor: 3.201

5.  Periacinar Clefting and p63 Immunostaining in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma.

Authors:  Bozo Kruslin; Davor Tomas; Aida Cviko; Hrvoje Cupic; Ljubica Odak; Mladen Belicza
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

6.  Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS.

Authors:  Xiaoxian Li; Mary R Schwartz; Jae Ro; Candice R Hamilton; Alberto G Ayala; Luan D Truong; Qihui Jim Zhai
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 7.  Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.

Authors:  Tamara Sequeiros; Marta García; Melania Montes; Mireia Oliván; Marina Rigau; Eva Colás; Inés de Torres; Juan Morote; Jaume Reventós; Andreas Doll
Journal:  Biomed Res Int       Date:  2013-11-25       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.